The US Food and Drug Administration (FDA) has approved an oral contraceptive (Safyral; Bayer Healthcare Pharmaceuticals, Inc) in which 451 μg levomefolate calcium has been added to each tablet of a 21/7 drospirenone 3 mg/estradiol 30 μg regimen.

Adverse events associated with use of folate-boosted oral contraceptives most commonly include premenstrual syndrome (12.4%), headache/migraine (10.3%), breast pain/tenderness/discomfort (8.1%), nausea/vomiting (4.4%), and abdominal soreness (2.2%).

From Medscape Medical News

If you are using the above or any other contraceptive and you suffer from PMS because of it, the Sonopathy Female Balance could help your body to deal with the premenstrual syndrome symptoms.